1 Sep 2020 17:35
AIM share code: SKIN
1 September 2020
Integumen PLC
("Integumen" or "Company")
Notice of AGM
Integumen announces that it has today sent a Notice of Annual General Meeting ("AGM") to shareholder convening a meeting for midday on 24 September 2020.
The meeting will be held at the offices of Jeffreys Henry LLP at Finsgate, 5-7 Cranwood Street, London EC1V 9EE.
The Company has noted the provisions of the newly enacted Corporate Insolvency and Governance Act 2020 ("CIGA") as well as the Government's advice that non-essential travel and gatherings should be avoided. Under the provisions of CIGA the requirements for a physical quorum to be present at the AGM and for the AGM to be held in a particular place have been suspended.
In the light of the above, and in order to ensure the safety of its shareholders, officers and employees, the Board requests that no Shareholders physically attend the AGM. Shareholders should note that only the business set out in the notice of AGM will be considered at the AGM. The Company will ensure that the legal requirements to hold the AGM can be satisfied through the attendance of a minimum number of Directors or employee shareholders, either in person or by electronic means. Any Board members in attendance will not meet with any Shareholders who attempt to attend the physical location of the AGM. Any shareholders that do attempt to attend at the AGM's location will be refused entry.
The Company does value shareholder participation and values the votes of shareholders, so it encourages all Shareholders to exercise their voting rights by completing and submitting a proxy form. Please note that due to restricted attendance, the chairman of the meeting will be appointed as each Shareholder's proxy. The appointment of anyone other than the chairman of the AGM as a Shareholder's proxy will not be valid and will be deemed to be an appointment of the chairman of the AGM as that Shareholder's proxy.
The only votes that will be counted at the AGM are those in respect of which valid proxies have been received by the Company's registrars by the relevant date for their receipt.
Integumen is pleased to announce that the Board of Integumen will provide a live investor presentation via the Investor Meet Company platform on 24 September at midday to enable shareholders to ask questions in the same way as they would at a normally held annual general meeting.
Shareholders can register on the attached weblink :
https://www.investormeetcompany.com/integumen-plc/register-investor
A copy of the notice is available on the Company's website www.integumen.com
Integumen plc | Gerard Brandon, CEO | +44 (0) 7340 055 648 |
SPARK Advisory Partners Limited (Nominated Adviser) | Neil Baldwin/Andrew Emmott | +44 (0) 113 370 8974 |
Turner Pope Investments (TPI) Limited (Broker) | Andy Thacker/Zoe Alexander | +44 (0) 20 3657 0050 |
About Integumen plc:
Integumen is a scientific research and AI-as-a-Service company focused on production and analysis of bacteria, virus and toxins utilising artificial intelligent data analytics in regulatory technology, from scientifically proving the impact of skincare product claims on skin microbiome for top 10 global cosmetic company clients to remotely detecting water contamination in real-time.